Global Herpes Marker Testing Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 3663

Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.
In 2018, the global Herpes Marker Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Herpes Marker Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Marker Testing development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics

Market segment by Type, the product can be split into
HSV-1
HSV-2
HSV-1/ HSV-2

Market segment by Application, split into
Research
Clinic

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Herpes Marker Testing status, future forecast, growth opportunity, key market and key players.
To present the Herpes Marker Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Herpes Marker Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Herpes Marker Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 HSV-1
1.4.3 HSV-2
1.4.4 HSV-1/ HSV-2
1.5 Market by Application
1.5.1 Global Herpes Marker Testing Market Share by Application (2014-2025)
1.5.2 Research
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Herpes Marker Testing Market Size
2.2 Herpes Marker Testing Growth Trends by Regions
2.2.1 Herpes Marker Testing Market Size by Regions (2014-2025)
2.2.2 Herpes Marker Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Herpes Marker Testing Market Size by Manufacturers
3.1.1 Global Herpes Marker Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Herpes Marker Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Herpes Marker Testing Market Concentration Ratio (CR5 and HHI)
3.2 Herpes Marker Testing Key Players Head office and Area Served
3.3 Key Players Herpes Marker Testing Product/Solution/Service
3.4 Date of Enter into Herpes Marker Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Herpes Marker Testing Market Size by Type (2014-2019)
4.2 Global Herpes Marker Testing Market Size by Application (2014-2019)

5 United States
5.1 United States Herpes Marker Testing Market Size (2014-2019)
5.2 Herpes Marker Testing Key Players in United States
5.3 United States Herpes Marker Testing Market Size by Type
5.4 United States Herpes Marker Testing Market Size by Application

6 Europe
6.1 Europe Herpes Marker Testing Market Size (2014-2019)
6.2 Herpes Marker Testing Key Players in Europe
6.3 Europe Herpes Marker Testing Market Size by Type
6.4 Europe Herpes Marker Testing Market Size by Application

7 China
7.1 China Herpes Marker Testing Market Size (2014-2019)
7.2 Herpes Marker Testing Key Players in China
7.3 China Herpes Marker Testing Market Size by Type
7.4 China Herpes Marker Testing Market Size by Application

8 Japan
8.1 Japan Herpes Marker Testing Market Size (2014-2019)
8.2 Herpes Marker Testing Key Players in Japan
8.3 Japan Herpes Marker Testing Market Size by Type
8.4 Japan Herpes Marker Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Herpes Marker Testing Market Size (2014-2019)
9.2 Herpes Marker Testing Key Players in Southeast Asia
9.3 Southeast Asia Herpes Marker Testing Market Size by Type
9.4 Southeast Asia Herpes Marker Testing Market Size by Application

10 India
10.1 India Herpes Marker Testing Market Size (2014-2019)
10.2 Herpes Marker Testing Key Players in India
10.3 India Herpes Marker Testing Market Size by Type
10.4 India Herpes Marker Testing Market Size by Application

11 Central & South America
11.1 Central & South America Herpes Marker Testing Market Size (2014-2019)
11.2 Herpes Marker Testing Key Players in Central & South America
11.3 Central & South America Herpes Marker Testing Market Size by Type
11.4 Central & South America Herpes Marker Testing Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Herpes Marker Testing Introduction
12.1.4 Abbott Laboratories Revenue in Herpes Marker Testing Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Abcam Plc
12.2.1 Abcam Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Herpes Marker Testing Introduction
12.2.4 Abcam Plc Revenue in Herpes Marker Testing Business (2014-2019)
12.2.5 Abcam Plc Recent Development
12.3 BioMérieux SA
12.3.1 BioMérieux SA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Herpes Marker Testing Introduction
12.3.4 BioMérieux SA Revenue in Herpes Marker Testing Business (2014-2019)
12.3.5 BioMérieux SA Recent Development
12.4 Thermo Fisher Scientific, Inc.
12.4.1 Thermo Fisher Scientific, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Herpes Marker Testing Introduction
12.4.4 Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2014-2019)
12.4.5 Thermo Fisher Scientific, Inc. Recent Development
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 F. Hoffmann-La Roche Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Herpes Marker Testing Introduction
12.5.4 F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2014-2019)
12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
12.6 DiaSorin S.p.A.
12.6.1 DiaSorin S.p.A. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Herpes Marker Testing Introduction
12.6.4 DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2014-2019)
12.6.5 DiaSorin S.p.A. Recent Development
12.7 Quidel Corporation
12.7.1 Quidel Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Herpes Marker Testing Introduction
12.7.4 Quidel Corporation Revenue in Herpes Marker Testing Business (2014-2019)
12.7.5 Quidel Corporation Recent Development
12.8 Luminex Corporation
12.8.1 Luminex Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Herpes Marker Testing Introduction
12.8.4 Luminex Corporation Revenue in Herpes Marker Testing Business (2014-2019)
12.8.5 Luminex Corporation Recent Development
12.9 Merck KGaA
12.9.1 Merck KGaA Company Details
12.9.2 Company Description and Business Overview
12.9.3 Herpes Marker Testing Introduction
12.9.4 Merck KGaA Revenue in Herpes Marker Testing Business (2014-2019)
12.9.5 Merck KGaA Recent Development
12.10 Qiagen N.V.
12.10.1 Qiagen N.V. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Herpes Marker Testing Introduction
12.10.4 Qiagen N.V. Revenue in Herpes Marker Testing Business (2014-2019)
12.10.5 Qiagen N.V. Recent Development
12.11 Norgen Biotek Corp.
12.12 Hologic Inc.
12.13 Bio Rad Laboratories Inc.
12.14 Meridian Bioscience Inc
12.15 Teco Diagnostics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details